GGrantIndex
← Leaderboards

Michelle M Mielke

Johns Hopkins University

$17,814,864
Attributed
$37,053,923
Total exposure
16
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $8.9M · FY200725
$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$44,759,519 · 17

By mechanism

RF1$14,105,737 · 4
U01$10,036,208 · 2
U54$9,919,313 · 3
U24$5,472,632 · 1
R01$4,304,236 · 4
R21$773,793 · 2

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposS DiseaseDementiaAgingPathologyBaseBloodPlasmaImpaired CognitionCognitionClinicBiological MarkersNerve DegenerationAffectCognitiveSamplingPerformanceAmyloid Beta-ProteinCohortCognitive FunctionFutureRisk FactorsLongitudinal StudiesBrain

Grant awards (46)

Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network$1,787,678
U24 · FY2025 · AG · contact PI
Stress, Weathering, and Blood-Based Biomarkers of Alzheimer’s Disease$828,609
R01 · FY2025 · AG
"What is N?" Towards operationalizing neurodegeneration in Alzheimer's and related dementias$727,449
R01 · FY2025 · AG
Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias$334,342
R01 · FY2025 · AG
Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias$169,669
R01 · FY2025 · AG
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network$1,800,259
U24 · FY2024 · AG · contact PI
"What is N?" Towards operationalizing neurodegeneration in Alzheimer's and related dementias$793,724
R01 · FY2024 · AG
Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias$387,497
RF1 · FY2024 · AG
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network$1,884,695
U24 · FY2023 · AG · contact PI
Stress, Weathering, and Blood-Based Biomarkers of Alzheimer’s Disease: A Longitudinal Study of Low Income, Aging African Americans$434,599
RF1 · FY2023 · AG
Sex-specific risk factors and trajectories of blood biomarkers for Alzheimer's disease and related dementias$4,159,504
RF1 · FY2022 · AG
Stress, Weathering, and Blood-Based Biomarkers of Alzheimer’s Disease: A Longitudinal Study of Low Income, Aging African Americans$2,788,814
RF1 · FY2022 · AG
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease$1,537,273
U54 · FY2022 · AG
Project 1 - Effects of Bilateral Oophorectomy on Physical and Cognitive Aging$403,005
U54 · FY2022 · AG · contact PI
Leadership Administrative Core$44,188
U54 · FY2022 · AG · contact PI
"What is N?" Towards operationalizing neurodegeneration in Alzheimer's and related dementias$2,360,353
RF1 · FY2021 · AG
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease$1,537,273
U54 · FY2021 · AG
Project 1 - Effects of Bilateral Oophorectomy on Physical and Cognitive Aging$403,005
U54 · FY2021 · AG · contact PI
Leadership Administrative Core$44,188
U54 · FY2021 · AG · contact PI
Alzheimers Disease Patient Registry$3,874,548
U01 · FY2020 · AG
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease$1,546,861
U54 · FY2020 · AG · contact PI
Project 1 - Effects of Bilateral Oophorectomy on Physical and Cognitive Aging$403,005
U54 · FY2020 · AG · contact PI
Leadership Administrative Core$44,188
U54 · FY2020 · AG · contact PI
Alzheimers Disease Patient Registry$3,874,548
U01 · FY2019 · AG
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease$1,537,322
U54 · FY2019 · AG · contact PI
Project 1 - Effects of Bilateral Oophorectomy on Physical and Cognitive Aging$391,881
U54 · FY2019 · AG · contact PI
Leadership Administrative Core$44,188
U54 · FY2019 · AG · contact PI
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease$1,546,867
U54 · FY2018 · AG · contact PI
Project 1 - Effects of Bilateral Oophorectomy on Physical and Cognitive Aging$391,881
U54 · FY2018 · AG · contact PI
Sphingolipids and Inflammation in the Development and Progression of Alzheimer's$380,757
R01 · FY2018 · AG · contact PI
Leadership Administrative Core$44,188
U54 · FY2018 · AG · contact PI
Reproductive risk factors for Alzheimer's disease dementia and pathology$3,974,970
RF1 · FY2017 · AG
Sphingolipids and Inflammation in the Development and Progression of Alzheimer's$378,802
R01 · FY2017 · AG · contact PI
Sphingolipids and Inflammation in the Development and Progression of Alzheimer's$373,717
R01 · FY2016 · AG · contact PI
Sphingolipids and Inflammation in the Development and Progression of Alzheimer's$317,167
R01 · FY2015 · AG · contact PI
Longitudinal Study of Lipids and APOE in the Development of AD and AD Pathology$351,801
U01 · FY2014 · AG · contact PI
Longitudinal Study of Lipids and APOE in the Development of AD and AD Pathology$458,294
U01 · FY2013 · AG · contact PI
Longitudinal Study of Lipids and APOE in the Development of AD and AD Pathology$603,622
U01 · FY2012 · AG · contact PI
Longitudinal Study of Lipids and APOE in the Development of AD and AD Pathology$516,767
U01 · FY2011 · AG · contact PI
Longitudinal Study of Lipids and APOE in the Development of AD and AD Pathology$356,628
U01 · FY2010 · AG · contact PI
Longitudinal study of membrane lipids: pre-clinical Alzheimer's biomarkers$73,800
R03 · FY2010 · AG · contact PI
Longitudinal study of membrane lipids: pre-clinical Alzheimer's biomarkers$73,800
R03 · FY2009 · AG · contact PI
Development of blood lipid biomarkers for Alzheimer's disease progression$204,918
R21 · FY2008 · AG · contact PI
Blood-based lipid biomarkers reflective of Alzheimer-associated neurodegeneration$179,375
R21 · FY2008 · NS · contact PI
Blood-based lipid biomarkers reflective of Alzheimer-associated neurodegeneration$215,250
R21 · FY2007 · NS · contact PI
Development of blood lipid biomarkers for Alzheimer's disease progression$174,250
R21 · FY2007 · AG · contact PI